Your browser doesn't support javascript.
Haemoperfusion should only be used for COVID-19 in the context of randomized trials.
Clark, Edward G; Hiremath, Swapnil; McIntyre, Lauralyn; Wald, Ron; Hundemer, Gregory L; Joannidis, Michael.
  • Clark EG; Division of Nephrology, Department of Medicine, The Ottawa Hospital and University of Ottawa, Ottawa, ON, Canada. edclark@toh.ca.
  • Hiremath S; Division of Nephrology, Department of Medicine, The Ottawa Hospital and University of Ottawa, Ottawa, ON, Canada.
  • McIntyre L; Division of Critical Care, Department of Medicine, The Ottawa Hospital and University of Ottawa, Ottawa, ON, Canada.
  • Wald R; Division of Nephrology, St Michael's Hospital and Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Hundemer GL; Division of Nephrology, Department of Medicine, The Ottawa Hospital and University of Ottawa, Ottawa, ON, Canada.
  • Joannidis M; Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.
Nat Rev Nephrol ; 16(12): 697-699, 2020 12.
Article in English | MEDLINE | ID: covidwho-766110

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Hemoperfusion / Coronavirus Infections / Betacoronavirus Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Nat Rev Nephrol Journal subject: Nephrology Year: 2020 Document Type: Article Affiliation country: S41581-020-00352-9

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Hemoperfusion / Coronavirus Infections / Betacoronavirus Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Nat Rev Nephrol Journal subject: Nephrology Year: 2020 Document Type: Article Affiliation country: S41581-020-00352-9